REQUEST A DEMO
Total
USD $0.00
Search more companies

Velevi Farma OOD (Фарнетикс ЕООД) (Bulgaria)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Velevi Farma OOD Profile Updated: September 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Velevi Farma OOD (Фарнетикс ЕООД) is a company based in Bulgaria, with its head office in Sofia. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on May 28, 2005. It currently has a total number of 79 (2024) employees. From the latest financial highlights, Velevi Farma OOD (Фарнетикс ЕООД) reported a net sales revenue drop of 15.12% in 2024. Its’ total assets recorded a growth of 9.37%. In, 2024, the company’s net profit margin increased by 1.18%.

Headquarters
Georgi Sofiyski 1A
Sofia; Sofia - city; Postal Code: 1431

Contact Details: Purchase the Velevi Farma OOD (Фарнетикс ЕООД) report to view the information.

Website: http://velevipharma.com

Basic Information
Total Employees:
Purchase the Velevi Farma OOD (Фарнетикс ЕООД) report to view the information.
Registered Capital:
Purchase the Velevi Farma OOD (Фарнетикс ЕООД) report to view the information.
Financial Auditors:
Purchase the Velevi Farma OOD (Фарнетикс ЕООД) report to view the information.
Incorporation Date:
May 28, 2005
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Company Performance
Financial values in the chart are available after Velevi Farma OOD (Фарнетикс ЕООД) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-15.12%▼
Total Operating Revenue
-15.23%▼
Operating Profit
55.21%▲
EBITDA
-16.13%▼
Net Profit/Loss for the Period
75.14%▲
Total Assets
9.37%▲
Total Equity
18.18%▲
Operating Profit Margin
1.42%▲
Net Profit Margin
1.18%▲
Return on Equity (ROE)
4.97%▲
Debt / Equity
-25.74%▼
Quick Ratio
0.07%▲

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?